Related references
Note: Only part of the references are listed.Potential of Nonpeptide (Ant)agonists to Rescue Vasopressin V2 Receptor Mutants for the Treatment of X-linked Nephrogenic Diabetes Insipidus
E. L. Los et al.
JOURNAL OF NEUROENDOCRINOLOGY (2010)
Phosphorylation of aquaporin-2 regulates its endocytosis and protein-protein interactions
Hanne B. Moeller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Quantitative analysis of aquaporin-2 phosphorylation
Luke Xie et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus
Jian Hua Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Functional Selectivity of Natural and Synthetic Prostaglandin EP4 Receptor Ligands
Martin Leduc et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Serine 269 phosphorylated aquaporin-2 is targeted to the apical membrane of collecting duct principal cells
Hanne B. Moeller et al.
KIDNEY INTERNATIONAL (2009)
Acute Hypertonicity Alters Aquaporin-2 Trafficking and Induces a MAPK-dependent Accumulation at the Plasma Membrane of Renal Epithelial Cells
Udo Hasler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Vasopressin-stimulated increase in phosphorylation at Ser269 potentiates plasma membrane retention of aquaporin-2
Jason D. Hoffert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Acute regulation of aquaporin-2 phosphorylation at Ser-264 by vasopressin
Robert A. Fenton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Vasopressin receptor mutations in nephrogenic diabetes insipidus
Daniel G. Bichet
SEMINARS IN NEPHROLOGY (2008)
Bypassing vasopressin receptor signaling pathways in nephrogenic diabetes insipidus
Richard Bouley et al.
SEMINARS IN NEPHROLOGY (2008)
Prostaglandin E receptors
Yukihiko Sugimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra)
R Bouley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
ONO-8815Ly, an EP2 agonist that markedly inhibits uterine contractions in women
M Steinwall et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2004)
Discovery of a potent and selective agonist of the prostaglandin EP4 receptor
X Billot et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Regulation of corticosterone production by vasopressin during water restriction and after drinking in rats
C Wotus et al.
NEUROENDOCRINOLOGY (2003)
Prostanoid receptors: Subtypes and signaling
RM Breyer et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Nitric oxide and atrial natriuretic factor stimulate cGMP-dependent membrane insertion of aquaporin 2 in renal epithelial cells
R Bouley et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)